Amarin Corp Plc (AMRN)

[ziploc_1]

After the success of the Reduce-It study in showing that Vascepa reduced the incidence of CVD, Dr. Nissin had a selfish reputational interest in finding faults with the study...criticisms that have now been debunked.

After the Brave study shows amelioration of Alzheimers disease, the leaders, associated with several companies, will have selfish monetary interests, leading them to criticize the study, itself, and its results...The Brave researchers will need to have ready, detailed answers to counter the criticisms... IMO they are still painstakingly going through the time consuming process of evaluating the results of the study in order to counter these inevitable criticisms.